SBC115 & SBC116 | SapiensBio Sapiensbio skip to Main Content


Data-Driven Technology-Based Drug Discovery Solution

SBC115 & SBC116

Fibrotic diseases manifest in various organs such as the liver, kidney, heart, pancreas, skin, and lungs. Given the exceptional therapeutic efficacy demonstrated by SBC101 in treating lung fibrosis, there is a strong indication for its potential applicability in addressing other fibrotic conditions. As a result, SapiensBio is actively pursuing the expansion of indications for SBC101. Recently, promising therapeutic effects on hepatic fibrosis have been confirmed through rigorous testing utilizing a human hepatic stellate cell model. Furthermore, preparations for a series of in vivo efficacy studies are currently underway

Back To Top